Chitooligosaccharide induces mitochondrial biogenesis and increases exercise endurance through the activation of Sirt1 and AMPK in rats

PLoS ONE

Volumn 7, Issue 7, 2012, Pages

  Jeong, Hyun Woo ^a   Cho, Si Young ^a   Kim, Shinae ^b   Shin, Eui Seok ^a   Kim, Jae Man ^a   Song, Min Jeong ^a   Park, Pil Joon ^a   Sohn, Jong Hee ^a   Park, Hyon ^b   Seo, Dae Bang ^a   Kim, Wan Gi ^a   Lee, Sang Jun ^a  

^a AmorePacific Corporation   (South Korea)

^b Kyung Hee University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

CHITOSAN DERIVATIVE; CHITOSE OLIGOSACCHARIDE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; OLIGOSACCHARIDE; SIRTUIN 1; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BIOGENESIS; CONTROLLED STUDY; ELECTRON TRANSPORT; ENDURANCE; EXERCISE; FEMALE; FOOD; MITOCHONDRION; MUSCLE CELL; NONHUMAN; RAT; SKELETAL MUSCLE;

ANIMALS; CELLS, CULTURED; CHITOSAN; ENERGY METABOLISM; ENZYME ACTIVATION; FEMALE; GENE EXPRESSION; HUMANS; MITOCHONDRIA, MUSCLE; MITOCHONDRIAL TURNOVER; MUSCLE FIBERS, SKELETAL; PHYSICAL CONDITIONING, ANIMAL; PHYSICAL ENDURANCE; PROTEIN KINASES; RATS; RATS, SPRAGUE-DAWLEY; SIRTUIN 1;

RATTUS; RODENTIA;

EID: 84863850485     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0040073     Document Type: Article

References (58)

1. Cuero RG, (1999) Antimicrobial action of exogenous chitosan. EXS 87: 315-333.
2. Dowling MB, Kumar R, Keibler MA, Hess JR, Bochicchio GV, et al. (2011) A self-assembling hydrophobically modified chitosan capable of reversible hemostatic action. Biomaterials 32: 3351-3357.
3. Gades MD, Stern JS, (2003) Chitosan supplementation and fecal fat excretion in men. Obes Res 11: 683-688.
4. Pusateri AE, McCarthy SJ, Gregory KW, Harris RA, Cardenas L, et al. (2003) Effect of a chitosan-based hemostatic dressing on blood loss and survival in a model of severe venous hemorrhage and hepatic injury in swine. J Trauma 54: 177-182.
5. Agnihotri SA, Mallikarjuna NN, Aminabhavi TM, (2004) Recent advances on chitosan-based micro- and nanoparticles in drug delivery. J Control Release 100: 5-28.
6. Choi BK, Kim KY, Yoo YJ, Oh SJ, Choi JH, et al. (2001) In vitro antimicrobial activity of a chitooligosaccharide mixture against Actinobacillus actinomycetemcomitans and Streptococcus mutans. Int J Antimicrob Agents 18: 553-557.
7. Tsai GJ, Wu ZY, Su WH, (2000) Antibacterial activity of a chitooligosaccharide mixture prepared by cellulase digestion of shrimp chitosan and its application to milk preservation. J Food Prot 63: 747-752.
8. Fernandes JC, Tavaria FK, Soares JC, Ramos OS, Joao Monteiro M, et al. (2008) Antimicrobial effects of chitosans and chitooligosaccharides, upon Staphylococcus aureus and Escherichia coli, in food model systems. Food Microbiol 25: 922-928.
9. Jung WK, Moon SH, Kim SK, (2006) Effect of chitooligosaccharides on calcium bioavailability and bone strength in ovariectomized rats. Life Sci 78: 970-976.
10. Yang Y, Liu M, Gu Y, Lin S, Ding F, et al. (2009) Effect of chitooligosaccharide on neuronal differentiation of PC-12 cells. Cell Biol Int 33: 352-356.
11. You Y, Park WH, Ko BM, Min BM, (2004) Effects of PVA sponge containing chitooligosaccharide in the early stage of wound healing. J Mater Sci Mater Med 15: 297-301.
12. Suzuki K, Mikami T, Okawa Y, Tokoro A, Suzuki S, et al. (1986) Antitumor effect of hexa-N-acetylchitohexaose and chitohexaose. Carbohydr Res 151: 403-408.
13. Huang R, Mendis E, Rajapakse N, Kim SK, (2006) Strong electronic charge as an important factor for anticancer activity of chitooligosaccharides (COS). Life Sci 78: 2399-2408.
14. Cho SY, Lee JH, Song MJ, Park PJ, Shin ES, et al. (2010) Effects of chitooligosaccharide lactate salt on sleep deprivation-induced fatigue in mice. Biol Pharm Bull 33: 1128-1132.
15. Scarpulla RC, (2008) Nuclear control of respiratory chain expression by nuclear respiratory factors and PGC-1-related coactivator. Ann N Y Acad Sci 1147: 321-334.
16. Puigserver P, Wu Z, Park CW, Graves R, Wright M, et al. (1998) A cold-inducible coactivator of nuclear receptors linked to adaptive thermogenesis. Cell 92: 829-839.
17. Jager S, Handschin C, St-Pierre J, Spiegelman BM, (2007) AMP-activated protein kinase (AMPK) action in skeletal muscle via direct phosphorylation of PGC-1alpha. Proc Natl Acad Sci U S A 104: 12017-12022.
18. Rodgers JT, Lerin C, Haas W, Gygi SP, Spiegelman BM, et al. (2005) Nutrient control of glucose homeostasis through a complex of PGC-1alpha and SIRT1. Nature 434: 113-118.
19. Gerhart-Hines Z, Rodgers JT, Bare O, Lerin C, Kim SH, et al. (2007) Metabolic control of muscle mitochondrial function and fatty acid oxidation through SIRT1/PGC-1alpha. EMBO J 26: 1913-1923.
20. Hardie DG, (2007) AMP-activated/SNF1 protein kinases: conserved guardians of cellular energy. Nat Rev Mol Cell Biol 8: 774-785.
21. Cohen HY, Miller C, Bitterman KJ, Wall NR, Hekking B, et al. (2004) Calorie restriction promotes mammalian cell survival by inducing the SIRT1 deacetylase. Science 305: 390-392.
22. Rogina B, Helfand SL, (2004) Sir2 mediates longevity in the fly through a pathway related to calorie restriction. Proc Natl Acad Sci U S A 101: 15998-16003.
23. Milne JC, Lambert PD, Schenk S, Carney DP, Smith JJ, et al. (2007) Small molecule activators of SIRT1 as therapeutics for the treatment of type 2 diabetes. Nature 450: 712-716.
24. Feige JN, Lagouge M, Canto C, Strehle A, Houten SM, et al. (2008) Specific SIRT1 activation mimics low energy levels and protects against diet-induced metabolic disorders by enhancing fat oxidation. Cell Metab 8: 347-358.
25. Zong H, Ren JM, Young LH, Pypaert M, Mu J, et al. (2002) AMP kinase is required for mitochondrial biogenesis in skeletal muscle in response to chronic energy deprivation. Proc Natl Acad Sci U S A 99: 15983-15987.
26. Bergeron R, Ren JM, Cadman KS, Moore IK, Perret P, et al. (2001) Chronic activation of AMP kinase results in NRF-1 activation and mitochondrial biogenesis. Am J Physiol Endocrinol Metab 281: E1340-1346.
27. Aquilano K, Vigilanza P, Baldelli S, Pagliei B, Rotilio G, et al. (2010) Peroxisome proliferator-activated receptor gamma co-activator 1alpha (PGC-1alpha) and sirtuin 1 (SIRT1) reside in mitochondria: possible direct function in mitochondrial biogenesis. J Biol Chem 285: 21590-21599.
28. Iwabu M, Yamauchi T, Okada-Iwabu M, Sato K, Nakagawa T, et al. (2010) Adiponectin and AdipoR1 regulate PGC-1alpha and mitochondria by Ca(2+) and AMPK/SIRT1. Nature 464: 1313-1319.
29. Lagouge M, Argmann C, Gerhart-Hines Z, Meziane H, Lerin C, et al. (2006) Resveratrol improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PGC-1alpha. Cell 127: 1109-1122.
30. Emerling BM, Viollet B, Tormos KV, Chandel NS, (2007) Compound C inhibits hypoxic activation of HIF-1 independent of AMPK. FEBS Lett 581: 5727-5731.
31. Kelley DE, He J, Menshikova EV, Ritov VB, (2002) Dysfunction of mitochondria in human skeletal muscle in type 2 diabetes. Diabetes 51: 2944-2950.
32. Gerbitz KD, Gempel K, Brdiczka D, (1996) Mitochondria and diabetes. Genetic, biochemical, and clinical implications of the cellular energy circuit. Diabetes 45: 113-126.
33. Patti ME, Corvera S, (2010) The role of mitochondria in the pathogenesis of type 2 diabetes. Endocr Rev 31: 364-395.
34. Biskup S, Moore DJ, (2006) Detrimental deletions: mitochondria, aging and Parkinson's disease. Bioessays 28: 963-967.
35. Chan DC, (2006) Mitochondria: dynamic organelles in disease, aging, and development. Cell 125: 1241-1252.
36. Bertoni-Freddari C, Fattoretti P, Paoloni R, Caselli U, Meier-Ruge W, (1997) Impaired dynamic morphology of cerebellar mitochondria in physiological aging and Alzheimer's disease. Ann N Y Acad Sci 826: 479-482.
37. Bartnik E, Lorenc A, Mroczek K, (2001) Human mitochondria in health, disease, ageing and cancer. J Appl Genet 42: 65-71.
38. Liesa M, Borda-d'Agua B, Medina-Gomez G, Lelliott CJ, Paz JC, et al. (2008) Mitochondrial fusion is increased by the nuclear coactivator PGC-1beta. PLoS One 3: e3613.
39. St-Pierre J, Lin J, Krauss S, Tarr PT, Yang R, et al. (2003) Bioenergetic analysis of peroxisome proliferator-activated receptor gamma coactivators 1alpha and 1beta (PGC-1alpha and PGC-1beta) in muscle cells. J Biol Chem 278: 26597-26603.
40. Lin J, Wu H, Tarr PT, Zhang CY, Wu Z, et al. (2002) Transcriptional co-activator PGC-1 alpha drives the formation of slow-twitch muscle fibres. Nature 418: 797-801.
41. Mootha VK, Lindgren CM, Eriksson KF, Subramanian A, Sihag S, et al. (2003) PGC-1alpha-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes. Nat Genet 34: 267-273.
42. Tiranti V, Rossi E, Ruiz-Carrillo A, Rossi G, Rocchi M, et al. (1995) Chromosomal localization of mitochondrial transcription factor A (TCF6), single-stranded DNA-binding protein (SSBP), and endonuclease G (ENDOG), three human housekeeping genes involved in mitochondrial biogenesis. Genomics 25: 559-564.
43. Canto C, Jiang LQ, Deshmukh AS, Mataki C, Coste A, et al. (2010) Interdependence of AMPK and SIRT1 for metabolic adaptation to fasting and exercise in skeletal muscle. Cell Metab 11: 213-219.
44. Sugiyama S, Yamada K, Ozawa T, (1995) Preservation of mitochondrial respiratory function by coenzyme Q10 in aged rat skeletal muscle. Biochem Mol Biol Int 37: 1111-1120.
45. Kon M, Kimura F, Akimoto T, Tanabe K, Murase Y, et al. (2007) Effect of Coenzyme Q10 supplementation on exercise-induced muscular injury of rats. Exerc Immunol Rev 13: 76-88.
46. Shimomura Y, Suzuki M, Sugiyama S, Hanaki Y, Ozawa T, (1991) Protective effect of coenzyme Q10 on exercise-induced muscular injury. Biochem Biophys Res Commun 176: 349-355.
47. Bryer SC, Goldfarb AH, (2006) Effect of high dose vitamin C supplementation on muscle soreness, damage, function, and oxidative stress to eccentric exercise. Int J Sport Nutr Exerc Metab 16: 270-280.
48. Nakhostin-Roohi B, Babaei P, Rahmani-Nia F, Bohlooli S, (2008) Effect of vitamin C supplementation on lipid peroxidation, muscle damage and inflammation after 30-min exercise at 75% VO2max. J Sports Med Phys Fitness 48: 217-224.
49. Stein E, Kushner H, Gidding S, Falkner B, (2007) Plasma lipid concentrations in nondiabetic African American adults: associations with insulin resistance and the metabolic syndrome. Metabolism 56: 954-960.
50. Davy BM, Davy KP, (2006) Comparison of assessment techniques: plasma lipid and lipoproteins related to the metabolic syndrome. Lipids Health Dis 5: 3.
51. Horowitz JF, (2007) Exercise-induced alterations in muscle lipid metabolism improve insulin sensitivity. Exerc Sport Sci Rev 35: 192-196.
52. Karacabey K, (2009) The effect of exercise on leptin, insulin, cortisol and lipid profiles in obese children. J Int Med Res 37: 1472-1478.
53. Kraus WE, Slentz CA, (2009) Exercise training, lipid regulation, and insulin action: a tangled web of cause and effect. Obesity (Silver Spring) 17: S21-26.
54. Lampman RM, Santinga JT, Savage PJ, Bassett DR, Hydrick CR, et al. (1985) Effect of exercise training on glucose tolerance, in vivo insulin sensitivity, lipid and lipoprotein concentrations in middle-aged men with mild hypertriglyceridemia. Metabolism 34: 205-211.
55. Carter RA, McCutcheon LJ, Valle E, Meilahn EN, Geor RJ, (2010) Effects of exercise training on adiposity, insulin sensitivity, and plasma hormone and lipid concentrations in overweight or obese, insulin-resistant horses. Am J Vet Res 71: 314-321.
56. Hirano S, Tsuchida H, Nagao N, (1989) N-acetylation in chitosan and the rate of its enzymic hydrolysis. Biomaterials 10: 574-576.
57. Brooks GA, White TP, (1978) Determination of metabolic and heart rate responses of rats to treadmill exercise. J Appl Physiol 45: 1009-1015.
58. Chabi B, Adhihetty PJ, O'Leary MF, Menzies KJ, Hood DA, (2009) Relationship between Sirt1 expression and mitochondrial proteins during conditions of chronic muscle use and disuse. J Appl Physiol 107: 1730-1735.